These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17159045)

  • 1. Retinopathy and choroidopathy as the initial signs of hypertensive brainstem encephalopathy.
    Albini TA; Lakhanpal RR; Foroozan R; Lopez GA; McPherson AR
    Arch Ophthalmol; 2006 Dec; 124(12):1784-6. PubMed ID: 17159045
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of exercise therapy alone and in combination with a calcium channel blocker or an angiotensin receptor blocker in hypertensive patients.
    Ohta M; Tajiri Y; Yamato H; Ikeda M
    Clin Exp Hypertens; 2012; 34(7):523-9. PubMed ID: 22559159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Control of systolic blood pressure in the VALUE trial after 12 months].
    Schmieder RE; Handrock R;
    Dtsch Med Wochenschr; 2003 Mar; 128(10):485-6. PubMed ID: 12627338
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of hypertensive encephalopathy involving the brain stem.
    Karasawa S; Kawanami T; Kimura H; Kurita K; Kato T
    Intern Med; 2004 May; 43(5):448-9. PubMed ID: 15206565
    [No Abstract]   [Full Text] [Related]  

  • 7. [MRI findings of hypertensive brainstem encephalopathy].
    Tada M; Kashida S; Shindo M; Kojima N
    No To Shinkei; 2004 Apr; 56(4):362-3. PubMed ID: 15237731
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertensive encephalopathy with predominant brain stem involvement: MRI findings.
    Karampekios SK; Contopoulou E; Basta M; Tzagournissakis M; Gourtsoyiannis N
    J Hum Hypertens; 2004 Feb; 18(2):133-4. PubMed ID: 14730329
    [No Abstract]   [Full Text] [Related]  

  • 9. Time to achieve blood pressure goal with a combination versus a conventional monotherapy approach in hypertensive patients with metabolic syndrome.
    Fogari R; Zoppi A; Ferrari I; Mugellini A; Preti P; Derosa G
    Clin Exp Hypertens; 2010; 32(5):245-50. PubMed ID: 20662723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
    [No Abstract]   [Full Text] [Related]  

  • 12. VALUE study highlights the need for aggressive BP lowering in high-risk patients.
    Cardiovasc J S Afr; 2004; 15(4):191-2, 195. PubMed ID: 15322578
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized lesions on MRI in a case of hypertensive brainstem encephalopathy.
    Ono Y; Manabe Y; Hamakawa Y; Murakami T; Omori N; Hayashi Y; Abe K
    Intern Med; 2005 Sep; 44(9):1002-5. PubMed ID: 16258222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM; Hilkert R
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients.
    Fogari R; Malamani G; Corradi L; Mugellini A; Preti P; Zoppi A; Derosa G
    Adv Ther; 2010 Jan; 27(1):48-55. PubMed ID: 20174905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):217-22. PubMed ID: 18356684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
    Kostis JB
    Am J Ther; 2010; 17(2):188-96. PubMed ID: 19433970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
    Prescrire Int; 2011 Mar; 20(114):67. PubMed ID: 21648225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.